Need of Beta 3 Agonist in Today's World as Oral Hypoglycaemic and Antiobesity


Affiliations

  • Govt. Medical College, Department of Pharmacology, Patiala, India

Abstract

No Abstract.

Keywords

no Keywords

Subject Discipline

Pharmacy and Pharmacology

Full Text:

References

Szepietowska B, Zhu W, Chan O, Horblitt A, Dziura J, Sherwin RS. Modulation of Beta Adrenergic Receptors in the Ventromedial Hypothalamus Influences Counter regulatory Responses to Hypoglycemia. Diabetes journal 2011;60: 3154-8.

Bahare RS, Gupta J, Malik S, Sharma N. New Emerging Targets for Type-2 Diabetes. International Journal of PharmTech Research 2011;3(2):809-18.

Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nature Med 2013;19:1252–63.

Coman OA, Paunescu H, Ghita I, Coman L, Badararu A, Fulga I. Beta 3 adrenergic receptors: molecular, histological, functional and pharmacological approaches. Romanian Journal of Morphology and Embryology 2009;50(2):169–79.

Abete I, Santiago NC, Marti A, Martinez JA. Nutrigenetics and Nutrigenomics of Caloric Restriction. Progress in Molecular Biology and Translational Science 2012;108:323-46.

Kurylowicz A. Stimulation of Thermogenesis via Beta-Adrenergic and Thyroid Hormone Receptors Agonists in Obesity Treatment – Possible Reasons for Therapy Resistance. J Pharmacogenomics Pharmacoproteomics 2015;6(1):1-7.


Refbacks

  • There are currently no refbacks.